A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Emory University
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Taofeek K. Owonikoko, Emory University
ClinicalTrials.gov Identifier:
First received: October 25, 2011
Last updated: August 24, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)